FILE PHOTO: The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed/File Photo
(Reuters) – The U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulnerabilities identified in Medtronic Plc’s implantable cardiac devices, clinic, programmers, and home monitoring.
But the FDA recommended the use of the devices and said that the medical device maker was the development of updates to further reduce those vulnerabilities. The health regulator added it was not aware of any reports of patients being harmed.
Last year, Medtronic disabled the internet updates for some of the 34,000 or phone programming devices that healthcare providers around the world to gain access to implanted pacemakers, saying, the system is vulnerable to cyber attacks.
Medical device makers have strengthened efforts to limit product vulnerabilities in the past few years, after a flurry of warnings from security researchers who have identified bugs in devices such as the Medtronic implant programmers.
Shares of the company were down 1 percent in after-hours trading.
Reporting by John Benny in Bengaluru; Editing by Chris Reese